Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TWO:4123 Center Ventures, founded in 1957, is based in Taiwan and has $1 billion in assets under management. Originally rooted in the pharmaceutical industry, the firm focuses on supporting innovation and entrepreneurship in the region. It primarily invests in early-stage startups across various sectors, with a strong emphasis on biotech and healthcare.
This firm invests in pre-seed, seed, and seed-plus stages, specifically targeting early-stage biotech and healthcare startups. TWO:4123 Center Ventures provides resources and support to help these startups grow and succeed in the Asian market.
Yes, TWO:4123 Center Ventures often leads investment rounds in early-stage startups, particularly in the biotech and healthcare sectors.
The firm is open to follow-on investments, especially for startups that demonstrate significant growth potential and align with their focus areas.
The firm manages assets totaling $1 billion, allowing for substantial investments in promising early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.